Kim Payne to Antineoplastic Agents
This is a "connection" page, showing publications Kim Payne has written about Antineoplastic Agents.
Connection Strength
0.207
-
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021 05; 35(5):1267-1278.
Score: 0.106
-
Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017 06; 50:1-12.
Score: 0.080
-
Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia. Adv Biol Regul. 2017 08; 65:16-25.
Score: 0.021